When I was eight years old, I fell from a bicycle and fractured two of my permanent front teeth. My mother was devastated. I, in my childlike confidence, told her not to worry — they would grow back.
They did not grow back, of course. But that question — why couldn’t we recreate what the human body had lost? — became the question that shaped my doctoral research, my postdoctoral work at Temple University, and ultimately the way I think about every patient who sits in my chair.
Today, that question is closer to having a clinical answer than at any point in dental history.
The Problem Biomaterials Science Is Trying to Solve
The core challenge in dental regeneration is this: teeth are composed of tissues — enamel, dentin, pulp, periodontal ligament, cementum — that the adult body cannot spontaneously regenerate after significant damage or loss.
Enamel, the hardest biological tissue in the body, is produced by ameloblasts — cells that are essentially programmed to die after the tooth erupts. Once the tooth is in the mouth, there is no cellular mechanism to produce new enamel. The body can partially remineralize early carious lesions — which is why fluoride and calcium-rich environments matter — but it cannot rebuild what has been genuinely lost.
Bone and periodontal ligament have better regenerative potential, but only under the right conditions — and even then, the regeneration is partial and requires clinical management to guide it.
The field of dental biomaterials research asks: what materials can we develop that work with the body’s healing biology to guide, support, and stimulate regeneration of dental tissues?
Where the Science Is Today
The research landscape in 2026 represents significant advances from even a decade ago:
Bioactive glasses and ceramics. These materials release ions — primarily silicon, calcium, and phosphate — that actively stimulate cellular activity in surrounding tissue. Bioactive glasses developed by Professor Larry Hench in the 1970s have evolved into a family of materials used in bone grafting, dentin remineralization, and hard tissue repair. The current generation of bioactive glass formulations can stimulate osteoblast (bone-forming cell) activity and support mineralization in ways that earlier graft materials could not.
Smart biomaterials. This was the focus of my own doctoral research — materials that respond to their environment. A smart biomaterial might release therapeutic agents (antibiotics, growth factors, remineralizing ions) in response to pH changes (as occur during bacterial acid production), temperature, or mechanical cues. The goal is a material that functions as a dynamic participant in healing rather than a passive scaffold.
Scaffold-based tissue engineering. Researchers are developing three-dimensional scaffolds — fabricated from biocompatible polymers, ceramics, or biologic materials — that can be seeded with progenitor cells and growth factors to guide the regeneration of dental pulp, periodontal ligament, or bone. Laboratory results have been promising. The translation to clinical practice is ongoing.
Platelet-rich plasma and growth factors. Autologous platelet concentrates — derived from the patient’s own blood — contain growth factors that support healing and are now used clinically to enhance bone graft integration, socket healing after extraction, and soft tissue repair.
What This Means for Patients Now
I want to be honest about the clinical reality: many of these developments are in the research or early clinical stages. Tooth regeneration — growing a complete new tooth from stem cells — remains a research goal, not a clinical reality, despite promising animal studies.
But several areas are already impacting patient care:
Remineralization therapy. For early enamel lesions — the stage before a cavity has formed — evidence-based remineralization protocols using fluoride, casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), and bioactive materials can reverse the process of mineral loss. The tooth that does not need a filling today because the lesion was caught and reversed is the best possible clinical outcome.
Bioceramic materials in endodontics. Third-generation bioceramics used in root canal treatment can be genuinely bioactive — stimulating the periapical tissues to heal and sometimes allowing regenerative healing of periapical lesions that would previously have been considered failures requiring extraction.
Guided bone regeneration. The combination of bone graft materials, barrier membranes, and growth factors has reached a level of clinical predictability that makes implant placement possible in sites where, a generation ago, there was insufficient bone.
Why Having a Researcher as Your Dentist Matters
Patients sometimes wonder what my PhD in engineering and biomaterials has to do with their treatment.
It means that when I evaluate a material for use in your care, I am not relying only on the manufacturer’s claims or a colleague’s anecdote. I have been trained to read and interpret research, to understand the limitations of studies, to distinguish between laboratory findings and clinical outcomes, and to apply evidence to individual decisions.
It means I ask the question that most dentists are not specifically trained to ask: what does the literature say about how this material behaves in the body over time?
And it means I believe, genuinely, in the direction this field is going — in the possibility that the dentistry of the next twenty years will preserve and regenerate more than it replaces, and that the curiosity a child had about growing back a broken tooth is, slowly, becoming science.
If you are interested in discussing how the most current evidence informs your treatment options, I invite you to schedule a consultation. The intersection of clinical care and scientific thinking is where our practice lives.